Celanese Corporation (CE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Celanese Corporation (CE) has a cash flow conversion efficiency ratio of 0.017x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($76.00 Million) by net assets ($4.49 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CE net asset quality index to measure how much of total assets are equity-financed.
Celanese Corporation - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Celanese Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Celanese Corporation's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Celanese Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Celanese Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Turkcell Iletisim Hizmetleri AS
NYSE:TKC
|
0.003x |
|
Anhui Yingliu
SHG:603308
|
0.017x |
|
Minera Frisco S.A.B. de C.V
MX:MFRISCOA-1
|
0.291x |
|
Companhia de Saneamento de Minas Gerais
SA:CSMG3
|
0.057x |
|
FORM.DE C.Y C.ADR 1/5/EO1
F:FCC0
|
N/A |
|
Xinfengming Group Co Ltd
SHG:603225
|
0.089x |
|
Allfunds Group Ltd
AS:ALLFG
|
0.264x |
|
Banpu Public Company Limited
BK:BANPU
|
0.016x |
Annual Cash Flow Conversion Efficiency for Celanese Corporation (2001–2025)
The table below shows the annual cash flow conversion efficiency of Celanese Corporation from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see CE market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $4.47 Billion | $1.15 Billion | 0.256x | +48.80% |
| 2024-12-31 | $5.61 Billion | $966.00 Million | 0.172x | -31.51% |
| 2023-12-31 | $7.55 Billion | $1.90 Billion | 0.251x | -15.61% |
| 2022-12-31 | $6.11 Billion | $1.82 Billion | 0.298x | -23.06% |
| 2021-12-31 | $4.54 Billion | $1.76 Billion | 0.387x | +77.46% |
| 2020-12-31 | $3.90 Billion | $850.00 Million | 0.218x | -56.50% |
| 2019-12-31 | $2.90 Billion | $1.45 Billion | 0.502x | +8.81% |
| 2018-12-31 | $3.38 Billion | $1.56 Billion | 0.461x | +89.43% |
| 2017-12-31 | $3.30 Billion | $803.00 Million | 0.243x | -17.66% |
| 2016-12-31 | $3.02 Billion | $893.00 Million | 0.296x | -2.99% |
| 2015-12-31 | $2.83 Billion | $862.00 Million | 0.305x | -2.51% |
| 2014-12-31 | $3.08 Billion | $962.00 Million | 0.313x | +10.70% |
| 2013-12-31 | $2.70 Billion | $762.00 Million | 0.282x | -32.35% |
| 2012-12-31 | $1.73 Billion | $722.00 Million | 0.417x | -12.28% |
| 2011-12-31 | $1.34 Billion | $638.00 Million | 0.476x | -2.74% |
| 2010-12-31 | $924.00 Million | $452.00 Million | 0.489x | -52.07% |
| 2009-12-31 | $584.00 Million | $596.00 Million | 1.021x | -67.96% |
| 2008-12-31 | $184.00 Million | $586.00 Million | 3.185x | +500.38% |
| 2007-12-31 | $1.07 Billion | $566.00 Million | 0.530x | -39.18% |
| 2006-12-31 | $861.00 Million | $751.00 Million | 0.872x | -63.47% |
| 2005-12-31 | $299.00 Million | $714.00 Million | 2.388x | +1638.91% |
| 2004-12-31 | $406.00 Million | $-63.00 Million | -0.155x | -200.61% |
| 2003-12-31 | $2.60 Billion | $401.00 Million | 0.154x | -10.95% |
| 2002-12-31 | $2.10 Billion | $363.00 Million | 0.173x | -26.75% |
| 2001-12-31 | $1.95 Billion | $462.00 Million | 0.236x | -- |
About Celanese Corporation
Celanese Corporation produces and sells engineered polymers worldwide. It operates through Engineered Materials and Acetyl Chain segments. The company offers ethylene acrylic elastomers, ethylene vinyl acetate pharmaceutical grade copolymers, liquid crystal polymers, long-fiber reinforced thermoplastics, nylon and polypropylene compounds and formulations, polyoxymethylene, ultra-high molecular we… Read more